Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3754011010 | Product containing only galcanezumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3754012015 | Galcanezumab only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2839071000001112 | Galcanezumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 2839081000001114 | Galcanezumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galcanezumab | Is a | Product containing galcanezumab (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Galcanezumab | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Galcanezumab | Has active ingredient | Galcanezumab | true | Inferred relationship | Existential restriction modifier | 1 | |
| Galcanezumab | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Galcanezumab | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only galcanezumab in parenteral dose form (medicinal product form) | Is a | True | Galcanezumab | Inferred relationship | Existential restriction modifier | |
| Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices | Is a | True | Galcanezumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR